| CPRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CPRX Market Cap History CPRX YTD Return |
| CPRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+13.47% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CPRX Stock Price Chart |
| About Catalyst Pharmaceuticals Inc |
| Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class medicines for rare and difficult-to-treat diseases. Its flagship product, FIRDAPSE (amifampridine) tablets, is approved for treating Lambert-Eaton Myasthenic Syndrome (LEMS) in adults and children aged six to seventeen. The company also markets FYCOMPA (perampanel) CIII for treating focal onset seizures and primary generalized tonic-clonic seizures in people with epilepsy. Additionally, its portfolio includes AGAMREE (vamorolone), an oral suspension for treating Duchenne Muscular Dystrophy (DMD), which is a corticosteroid treatment for DMD patients. We show 66 historical shares outstanding datapoints in our coverage of CPRX's shares outstanding history. Understanding the changing numbers of CPRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CPRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CPRX by allowing them to research CPRX shares outstanding history as well as any other stock in our coverage universe. |
| CPRX Current Stock Quote |
 Free CPRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CPRX Share Performance |
| Shares Outstanding Peers |
| Catalyst Pharmaceuticals (CPRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CRBP Shares Outstanding History |
